Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...
Georgetown University psychologist Shadab Tabatabaeian, the paper’s lead author, imagines a “cool application” of their ...
Vertex, Inc. (NASDAQ: VERX) posted double-digit revenue growth in the third quarter of 2025 and announced its first-ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback